42
Views
94
CrossRef citations to date
0
Altmetric
Cell Growth and Development

The Endothelial Cell-Specific Antibody PAL-E Identifies a Secreted Form of Vimentin in the Blood Vasculature

, , , , &
Pages 9198-9206 | Received 28 Jan 2004, Accepted 21 Jul 2004, Published online: 27 Mar 2023

REFERENCES

  • Ades, E. W., Candal F. J., Swerlick R. A., George V. G., Summers S., Bosse D. C., and Lawley T. J.. 1992. HMEC-1: establishment of an immortalized human microvascular endothelial cell line. J. Investig. Dermatol. 99:683–690.
  • Carmeliet, P. 2003. Angiogenesis in health and disease. Nat. Med. 9:653–660.
  • Chen, H., Locke D., Liu Y., Liu C., and Kahn M. L.. 2002. The platelet receptor GPVI mediates both adhesion and signaling responses to collagen in a receptor density-dependent fashion. J. Biol. Chem. 277:3011–3019.
  • Colucci-Guyon, E., Portier M. M., Dunia I., Paulin D., Pournin S., and Babinet C.. 1994. Mice lacking vimentin develop and reproduce without an obvious phenotype. Cell 79:679–694.
  • Diacovo, T. G., Puri K. D., Warnock R. A., Springer T. A., and von Andrian U. H.. 1996. Platelet-mediated lymphocyte delivery to high endothelial venules. Science 273:252–255.
  • Eckes, B., Colucci-Guyon E., Smola H., Nodder S., Babinet C., Krieg T., and Martin P.. 2000. Impaired wound healing in embryonic and adult mice lacking vimentin. J. Cell Sci. 113:2455–2462.
  • Erhard, H., Rietveld F. J., Brocker E. B., de Waal R. M., and Ruiter D. J.. 1996. Phenotype of normal cutaneous microvasculature. Immunoelectron microscopic observations with emphasis on the differences between blood vessels and lymphatics. J. Investig. Dermatol. 106:135–140.
  • Evans, R. M. 1998. Vimentin: the conundrum of the intermediate filament gene family. Bioessays 20:79–86.
  • Franke, W. W., Schmid E., Winter S., Osborn M., and Weber K.. 1979. Widespread occurrence of intermediate-sized filaments of the vimentin-type in cultured cells from diverse vertebrates. Exp. Cell Res. 123:25–46.
  • Fuchs, E., and Weber K.. 1994. Intermediate filaments: structure, dynamics, function, and disease. Annu. Rev. Biochem. 63:345–382.
  • Garlanda, C., and Dejana E.. 1997. Heterogeneity of endothelial cells. Specific markers. Arterioscler. Thromb. Vasc. Biol. 17:1193–1202.
  • Leenstra, S., Troost D., Das P. K., Claessen N., Becker A. E., and Bosch D. A.. 1993. Endothelial cell marker PAL-E reactivity in brain tumor, developing brain, and brain disease. Cancer 72:3061–3067.
  • Leenstra, S., Das P. K., Troost D., Bosch D. A., Claessen N., and Becker A. E.. 1990. PAL-E, monoclonal antibody with immunoreactivity for endothelium specific to brain tumours. Lancet 335:671.
  • Mor-Vaknin, N., Punturieri A., Sitwala K., and Markovitz D. M.. 2003. Vimentin is secreted by activated macrophages. Nat. Cell Biol. 5:59–63.
  • Muller, W. A., and Weigl S. A.. 1992. Monocyte-selective transendothelial migration: dissection of the binding and transmigration phases by an in vitro assay. J. Exp. Med. 176:819–828.
  • Nishimura, N., and Balch W. E.. 1997. A di-acidic signal required for selective export from the endoplasmic reticulum. Science 277:556–558.
  • Oliver, G., and Detmar M.. 2002. The rediscovery of the lymphatic system: old and new insights into the development and biological function of the lymphatic vasculature. Genes Dev. 16:773–783.
  • Page, C., Rose M., Yacoub M., and Pigott R.. 1992. Antigenic heterogeneity of vascular endothelium. Am. J. Pathol. 141:673–683.
  • Perides, G., Harter C., and Traub P.. 1987. Electrostatic and hydrophobic interactions of the intermediate filament protein vimentin and its amino terminus with lipid bilayers. J. Biol. Chem. 262:13742–13749.
  • Podor, T. J., Singh D., Chindemi P., Foulon D. M., McKelvie R., Weitz J. I., Austin R., Boudreau G., and Davies R.. 2002. Vimentin exposed on activated platelets and platelet microparticles localizes vitronectin and plasminogen activator inhibitor complexes on their surface. J. Biol. Chem. 277:7529–7539.
  • Risau, W. 1997. Mechanisms of angiogenesis. Nature 386:671–674.
  • Ruiter, D. J., Schlingemann R. O., Westphal J. R., Denijn M., Rietveld F. J., and De Waal R. M.. 1993. Angiogenesis in wound healing and tumor metastasis. Behring Inst. Mitt 1993:258–272.
  • Ruiter, D. J., Schlingemann R. O., Rietveld F. J., and de Waal R. M.. 1989. Monoclonal antibody-defined human endothelial antigens as vascular markers. J. Investig. Dermatol. 93:25S–32S.
  • Sauter, B., Foedinger D., Sterniczky B., Wolff K., and Rappersberger K.. 1998. Immunoelectron microscopic characterization of human dermal lymphatic microvascular endothelial cells. Differential expression of CD31, CD34, and type IV collagen with lymphatic endothelial cells vs blood capillary endothelial cells in normal human skin, lymphangioma, and hemangioma in situ. J. Histochem. Cytochem. 46:165–176.
  • Schlingemann, R. O., Dingjan G. M., Emeis J. J., Blok J., Warnaar S. O., and Ruiter D. J.. 1985. Monoclonal antibody PAL-E specific for endothelium. Lab. Investig. 52:71–76.
  • Sleeman, J. P., Krishnan J., Kirkin V., and Baumann P.. 2001. Markers for the lymphatic endothelium: in search of the holy grail? Microsc. Res. Tech. 55:61–69.
  • Turowski, P., Myles T., Hemmings B. A., Fernandez A., and Lamb N. J.. 1999. Vimentin dephosphorylation by protein phosphatase 2A is modulated by the targeting subunit B55. Mol. Biol. Cell 10:1997–2015.
  • Yasui, Y., Goto H., Matsui S., Manser E., Lim L., Nagata K., and Inagaki M.. 2001. Protein kinases required for segregation of vimentin filaments in mitotic process. Oncogene 20:2868–2876.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.